Alumis ALMS
NASDAQ ALMS
$6.55 -0.07 (-1.06%)
As of: Nov 12, 2026 · 10:51 AM EST

Alumis (ALMS) Return on Sales [ROS] (2025 - 2026)

Updated

Alumis' Return on Sales [ROS] came in at -8956.38% for Q2 2026, down 3684.85 percentage points from -5271.53% a year earlier.

Analysis

Alumis (ALMS) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alumis reported Return on Sales [ROS] of -6021.04%; for FY2025, it was -1886.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Alumis 796.45 Mn -915.01 Mn - -8,956.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,956.38%
Mar 31, 2026 -5,652.44%
Dec 31, 2025 -4,999.74%
Sep 30, 2025 -5,580.45%
Jun 30, 2025 -5,271.53%
Mar 31, 2025 -583.86%
API Access

Alumis Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALMS&period=max&api_key=YOUR_API_KEY